ATE537839T1 - Impfstoff zum schutz gegen staphylococcus aureus auf der basis zellwandassoziierter proteine - Google Patents

Impfstoff zum schutz gegen staphylococcus aureus auf der basis zellwandassoziierter proteine

Info

Publication number: ATE537839T1
Authority: AT; Austria
Prior art keywords: staphylococcus aureus; cell wall; vaccine; protection against; associated proteins
Prior art date: 2007-05-04

Application number

AT07107512T

Other languages

English (en)

Inventor

Martin Kroenke

Oleg Krut

Eva Glowalla

Bettina Tosetti

Original Assignee

Martin Kroenke

Oleg Krut

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-05-04

Filing date

2007-05-04

Publication date

2012-01-15

2007-05-04 Application filed by Martin Kroenke, Oleg Krut filed Critical Martin Kroenke

2012-01-15 Application granted granted Critical

2012-01-15 Publication of ATE537839T1 publication Critical patent/ATE537839T1/de

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Gram-positive bacteria
- C07K16/1271—Micrococcaceae (F); Staphylococcaceae (F), e.g. Staphylococcus (G)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/77—Internalization into the cell

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

AT07107512T 2007-05-04 2007-05-04 Impfstoff zum schutz gegen staphylococcus aureus auf der basis zellwandassoziierter proteine ATE537839T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP07107512A EP1987836B1 (de)	2007-05-04	2007-05-04	Impfstoff zum Schutz gegen staphylococcus aureus auf der Basis zellwandassoziierter Proteine

Publications (1)

Publication Number	Publication Date
ATE537839T1 true ATE537839T1 (de)	2012-01-15

Family

ID=38895836

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT07107512T ATE537839T1 (de)	2007-05-04	2007-05-04	Impfstoff zum schutz gegen staphylococcus aureus auf der basis zellwandassoziierter proteine

Country Status (3)

Country	Link
US (1)	US20080299127A1 (de)
EP (3)	EP1987836B1 (de)
AT (1)	ATE537839T1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2012065034A1 (en) *	2010-11-12	2012-05-18	Merck Sharp & Dohme Corp.	Enolase peptide conjugate vaccines against staphylococcus aureus
WO2013066731A2 (en)	2011-10-31	2013-05-10	Merck Sharp & Dohme Corp.	Protective vaccine based on staphylococcus aureus sa2451 protein
EP2872173A4 (de)	2012-07-10	2016-03-23	Merck Sharp & Dohme	Schutzimpfstoff auf grundlage des staphylococcus-aureus-proteins sa2493
EP3363459A1 (de)	2017-02-17	2018-08-22	Alexander Klimka	Polypeptid-epitope von s. aureus und entsprechende monoklonale antikörper zur behandlung von infektionen und immundiagnose
CN114088946B (zh) *	2021-07-02	2024-03-29	中国科学技术大学	转录调控因子WalR和MgrA的亚硝基化修饰在治疗金黄色葡萄球菌感染中的应用
CN115359854B (zh) *	2021-11-03	2026-07-21	昆明理工大学	达舒平的抗菌应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0107661D0 (en) *	2001-03-27	2001-05-16	Chiron Spa	Staphylococcus aureus
EP1412379B1 (de) *	2001-08-02	2012-01-25	The University Of Sheffield	Impfstoff
NZ544542A (en) *	2003-07-24	2009-01-31	Merck & Co Inc	Polypeptides for inducing a protective immune response against staphylococcus aureus
ES2730275T3 (es) *	2004-09-22	2019-11-11	Glaxosmithkline Biologicals Sa	Composición inmunógena para uso en vacunación contra estafilococos

2007
- 2007-05-04 AT AT07107512T patent/ATE537839T1/de active
- 2007-05-04 EP EP07107512A patent/EP1987836B1/de not_active Not-in-force
- 2007-05-04 EP EP11169342.0A patent/EP2374466B1/de not_active Not-in-force
- 2007-05-04 EP EP11169347.9A patent/EP2374467B1/de active Active
2008
- 2008-05-05 US US12/115,282 patent/US20080299127A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20080299127A1 (en)	2008-12-04
EP2374467B1 (de)	2013-08-28
EP2374467A1 (de)	2011-10-12
EP2374466A1 (de)	2011-10-12
EP1987836A1 (de)	2008-11-05
EP1987836B1 (de)	2011-12-21
EP2374466B1 (de)	2013-08-28

Similar Documents

Publication	Publication Date	Title
CL2013001654A1 (es)	2014-03-28	Compuestos derivados de 6-amino-2-fenilamino-1h-bencimidazol-5-carboxamida; composicion farmaceutica; y su uso en el tratamiento y/o prevencion de las enfermedades inflamatorias y/o afecciones asociadas, en particular el dolor.
BRPI0813455A2 (pt)	2014-12-23	Derivado de 17beta-ciano-18a-homo-19-nor-androst-4-eno, seu uso e medicamentos contendo este derivado.
BRPI0814267A2 (pt)	2015-03-31	Agentes citotóxicos compreendendo novos derivados de tomaicmicina e o seu uso terapêutico.
BRPI0610850A2 (pt)	2008-12-02	derivados de Ácido aril alquila, composiÇço farmacÊutica, medicamento, bem como uso dos referidos derivados
MA28921B1 (fr)	2007-10-01	Derive heterocyclique azote et medicament le contenant en tant que principe actif
ATE536373T1 (de)	2011-12-15	Therapiemittel auf antikörperbasis mit erhöhter adcc-aktivität
HUE053113T2 (hu)	2021-06-28	Bardoxolon-metil 2,2-difluorpropionamid-származéka, annak gyógyszerkészítményei és polimorfjai bizonyos betegségek kezelésében történõ alkalmazásra
BR112012027034A2 (pt)	2016-07-19	inibidores da arginase e suas aplicações terapêuticas
HUE058787T2 (hu)	2022-09-28	Staphylococcus aureus leukocidinek, terápiás készítmények és azok felhasználása
FR2915199B1 (fr)	2010-01-22	Derives de triazolopyridine-carboxamides et triazolopyrimidine-carboxamides, leur preparation et leur application en therapeutique.
CY1120435T1 (el)	2019-07-10	Φαρμακοτεχνικες μορφες που περιλαμβανουν κρυσταλλικες μορφες του μονοενυδρου υδροχλωρικου (r)-7-χλωρο-ν-(κινουκλιδινο-3-υλο) βενζο(β)θειοφαινο-2-καρβοξαμιδιου
FR2910473B1 (fr)	2009-02-13	Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2- carboxamides, leur preparation et leur application en therapeutique.
UA107550C2 (uk)	2015-01-12	Похідні естра-1,3,5(10),16-тетраєн-3-карбоксаміду, способи їх одержання, фармацевтичні препарати, що їх містять, та їх застосування для виготовлення лікарських засобів
UA115232C2 (uk)	2017-10-10	Препарат, що містить аморфний емодепсид
EP1876178A4 (de)	2011-09-07	Cyanopyridinderivat und dessen verwendung als medizin
WO2008146172A3 (en)	2009-12-10	Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
BRPI0820985A2 (pt)	2015-06-16	Composto derivado de 5-aminociclometil-oxazondin-2-ona, medicamento e composição farmacêutica que os contém e uso dos mesmos
BRPI0809143A2 (pt)	2016-11-16	polimorfismos genéticos associados com eventos coronários e resposta a fármaco, métodos de detecção e usos dos mesmos
DE602005020693D1 (de)	2010-05-27	Verpackung für pharmazeutische, medizinische oder ähnliche produkte, besonders pestizide oder pflanzenschutzprodukte
EP2264031A4 (de)	2012-06-13	Neuartiges benzoxazin-benzimidazol-derivat, pharmazeutische zusammensetzung damit und verwendung davon
EP2322505A4 (de)	2011-10-19	1-adamantylazetidin-2-on-derivat, herstellung davon und pharmazeutisches präparat damit
BRPI0813937A2 (pt)	2014-12-30	Derivado de 17beta-ciano-19-nor-andros-4-eno, seu uso e medicamentos contendo o derivado
EP2402333A4 (de)	2012-08-01	1,4-benzothiazepin-1-oxidderivat und pharmazeutische zusammensetzung damit
WO2008033477A3 (en)	2008-07-17	Antimicrobial activity in variants of lacritin
EP2348019A4 (de)	2012-10-31	1,2-diazetidin-3-on-derivat und pharmazeutischer wirkstoff damit